Neumora's Phase 3 Trial Miss and a Trio of VC Raises
Watertown companies have now raised $245 million in VC funds in 2026
Watertown Journal Club - Improving Vaccine Immunogenicity with Corner Therapeutics
the very model of a modern adjuvant general
Triveni's New Digs, 99 Coolidge's Tenant Bonanza, and Remix's FDA Fast Track Designation
Plus Addgenes' new partnership, and Neumora and Acrivon's cash flow updates
What we're looking forward to in 2026
Neumora's positive clinical data , new tenants at the Arsenal, and more
Labshares Expanding to Watertown
Neumora's Wegovy alternative, Dyno announces manufacturing pact, and more